Sign Up to like & get
recommendations!
1
Published in 2022 at "Chembiochem"
DOI: 10.1002/cbic.202200183
Abstract: Psilocybin (1) is the major alkaloid found in psychedelic mushrooms and acts as a prodrug to psilocin (2, 4‐hydroxy‐N,N‐dimethyltryptamine), a potent psychedelic that exerts remarkable alteration of human consciousness. In contrast, the positional isomer bufotenin…
read more here.
Keywords:
psilocin;
pharmacology;
assessment bioactivity;
ring formation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Clinical Pharmacokinetics"
DOI: 10.1007/s40262-024-01454-4
Abstract: Psilocybin is currently being extensively studied as a potential therapeutic agent for multiple psychiatric disorders. Here, a systematic literature review of all published pharmacokinetic data on the pharmacologically active metabolite of psilocybin, psilocin, is presented.…
read more here.
Keywords:
psilocybin administration;
review;
psilocin;
clinical pharmacokinetics ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Medicinal Chemistry"
DOI: 10.1021/acs.jmedchem.4c02612
Abstract: As interest in using psilocybin therapy for treating mental health disorders intensifies, the need for efficient production methods becomes increasingly important. Current medical-grade psilocybin production is inefficient and relies on a complicated multistep synthesis. This…
read more here.
Keywords:
psilocin ester;
stability;
psilocin;
ester prodrugs ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuropsychopharmacology"
DOI: 10.1038/s41386-019-0324-9
Abstract: The main psychedelic component of magic mushrooms is psilocybin, which shows promise as a treatment for depression and other mental disorders. Psychedelic effects are believed to emerge through stimulation of serotonin 2A receptors (5-HT2ARs) by…
read more here.
Keywords:
plasma psilocin;
psilocin;
ht2ar occupancy;
occupancy ... See more keywords